
American burger chain to open second UK restaurant in Wales
American burger chain to open second UK restaurant in Wales
Carl's Jr chose Cardiff for its first UK location and its second will also be on Welsh shores
The chain is known for its famous charbroiled burgers
(Image: Carl's Jr )
Months after opening its first UK branch in Wales, Carl's Jr is gearing up to launch a new location. Signs of Carl's Jr arrival have been spotted by eagle-eyed locals on Swansea's Wind Street where the popular burger chain will be opening, taking one half of the former TGI Friday's restaurant.
With its signature American-style menu featuring favourites like the six dollar burger, hand-scooped milkshakes and charbroiled turkey burgers, Carl's Jr will be sharing the building with Slim Chickens, another American chain which recently confirmed its opening date for Thursday, June 26.
Founded in California in 1941 by Carl and Margaret Karcher, Carl's Jr is expanding across the UK and Ireland through a franchise agreement with Boporan Restaurant Grou, which also operates Gourmet Burger Kitchen, Carluccio's and Slim Chickens.
The branch promises to bring a slice of California to the streets of Swansea
(Image: Carl's Jr )
For the latest restaurant news and reviews, sign up to our food and drink newsletter here
Its first UK branch opened in Cardiff's St David's Centre earlier this year and the Swansea restaurant is expected to follow in early September, with a opening date to be confirmed.
Article continues below
After its opening WalesOnline tried the new Cardiff restaurant and you can read our verdict here.
Carl's Jr fans have taken to social media to express their excitement about the US chain's growing presence in the UK, with some claiming it's "better than McDonald's."
One user on X commented: "Carls JR is easily better than McDonald's Burger King and probably most of the other American fast food chains you have currently in the United Kingdom."
Another added: "Carls jr is better than Mcdonalds, el diablo is tasty as f**k".
Alongside the Swansea location, the Sun has reported that plans are well underway for five more Carl's Jr restaurants to open across the UK before the end of 2025.
These new sites will reportedly be located in Southampton, Bristol, Leeds, Manchester and York.
Article continues below
Ahead of the opening, a spokesperson from Carls Jr, said: "We are extremely excited and love the amount of Love the Welsh people are showing Carls Jr!"
Get daily breaking news updates on your phone by joining our WhatsApp community here . We occasionally treat members to special offers, promotions and ads from us and our partners. See our Privacy Notice
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scottish Sun
an hour ago
- Scottish Sun
Foreign investors looking to give Super League a huge money boost
Interest reported from the Middle East and USA, as well as the UK Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) SUPER League is being targeted by potential investors from the Middle East and the USA, with the next three months described as 'critical.' The NRL has long been linked with a buy-in to the competition on the other side of the world. Sign up for Scottish Sun newsletter Sign up 1 Super League is being targeted by foreign investors, including some from the USA, where Wigan and Warrington took the game with a match in Las Vegas Credit: But SunSport understands there are three other serious contenders looking at plunging money in. One may be linked to Saudi Arabia, which would tie into hopes streaming giant DAZN – which has strong links to the Arab nation –gets involved in a competition with Sky for the next broadcast deal. An American group is also examining the possibility of supporting Super League, but it is thought they are not linked to the disastrous buyout of Salford Red Devils. Interest based in the UK is also in the running, with the coming weeks set to see work done on making the sport in the Northern Hemisphere 'ready for investment.' That includes sorting a governance structure, mapping out how finance will develop the sport and what level of influence any investor will have. The NRL's much talked about move, which would bring all of rugby league under the same umbrella, is seen by many as the potential saviour of the sport. However, SunSport understands if they do come in, with a large level of control, it will not see cash plunged in. Instead, it is believed any return will come in the form of improved commercial deals. Bosses are said to be examining all the options on the table with one source saying: 'It's got to be the right investment, not just money to be spent in the same ways as always.'


NBC News
an hour ago
- NBC News
Trump's $499 smartphone will likely be made in China
The Trump Organization's newly announced smartphone will most likely be made in China, experts say, despite claims that the device will be manufactured in the U.S. Owned President Donald Trump, the company on Monday announced the T1, a gold-colored device that it said would retail for $499. The smartphone will run Google 's Android operating system. The Trump Organization says the phone will be 'built in the United States' — but experts note the phone was most likely designed and would be manufactured by a Chinese firm. 'There is no way the phone was designed from scratch and there is no way it is going to be assembled in the U.S. or completely manufactured in the U.S.,' Francisco Jeronimo, vice president at International Data Corp., told CNBC on Tuesday. 'That is completely impossible.' Jeronimo suggested that the phone would most likely be produced by a Chinese original device manufacturer, or ODM — a type of company that designs and manufactures products based on the specifications of another firm. 'Despite being advertised as an American-made phone, it is likely that this device will be initially produced by a Chinese ODM,' Blake Przesmicki, an analyst at Counterpoint Research, said in a note Monday. Jeff Fieldhack, research director at Counterpoint Research, added that 'the U.S. does not have local manufacturing capabilities readily available.' Smartphone manufacturing came into focus after Trump threatened tariffs on devices imported into the U.S. While those have yet to materialize, the American president has poured scrutiny on Apple 's supply chain, urging the iPhone maker to manufacture its flagship handset in the U.S. The call is part of a broader desire from Trump to see more manufacturing of electronics be undertaken in the U.S. Several experts have noted that manufacturing iPhones in the U.S. would be nearly impossible and would certainly raise the price of the product substantially. On top of that, getting large-scale manufacturing off the ground in the U.S. would take several years. Phone will need foreign components Even if some manufacturing of the device were done in the U.S., smartphone supply chains are global, and handset components come from several countries. The Trump Organization's T1 is no different. While no information has been revealed on particular components, the specifications could give a hint of what to expect. The device will have a 6.8-inch AMOLED display, a kind of screen that is made primarily by South Korean firm Samsung. LG, another South Korean firm, also produces the screen, as does Chinese firm BOE. For comparison, Apple's top-end iPhone 16 Pro Max has a 6.9-inch display and starts at $1,199. At T1's $499 price point, the smartphone will most likely use a processor from Taiwanese firm MediaTek, which would be manufactured in Taiwan. If the device were to contain a Qualcomm chip instead, that would also most likely have to be made in Taiwan. The phone's advertised 50-megapixel camera will meanwhile require image sensing chips — a market that is dominated by Japanese firm Sony for smartphones. There are smaller players in China and elsewhere. The device's memory is one area that could use American technology, potentially from Micron, which manufactures its components in the U.S. But other players, like Samsung, could be potential suppliers. 'Even when there is local manufacturing available, the company will have to rely on components that are being imported from outside the U.S.,' Counterpoint Research's Fieldhack said.


Business News Wales
an hour ago
- Business News Wales
£107m For Health Spinout is 'Most Significant Commercial Investment in Welsh Research To Date'
A clinical-stage spinout company is launching with a $140 million (£107 million) investment – the most significant commercial investment into Welsh research to date. Cardiff University spinout Draig Therapeutics will launch with the investment from leading international venture investors to advance the development of novel therapies for major neuropsychiatric disorders such as major depressive disorder. The university said this represents the most significant commercial investment into Welsh research to date. Founded on the research and expertise of Professor John Atack and Professor Simon Ward from Cardiff University's Medicines Discovery Institute, the new company will translate the latest research into new treatments for neuropsychiatric conditions. Draig Therapeutics will target key processes in the brain – the Glutamate and GABA pathways – to develop new and more effective treatment options. Professor Simon Ward, Cardiff University's Medicines Discovery Institute and Draig Therapeutics, said: 'We have unique scientific expertise in safely and effectively modulating the core Glutamate and GABA pathways in the brain, which play a critical role in neuropsychiatric disorders. Our knowledge of balancing the chemical neurotransmitters in the brain in neuropsychiatric conditions underpins Draig's pipeline of novel treatments. With the launch of Draig, we can test and develop these new treatments, to bring them into clinical practice and make genuine impacts on the lives of patients around the world.' Draig was formed through a partnership between Cardiff University's Medicine Discovery Institute and SV Health Investors and was founded in 2024. Draig Therapeutics is due to launch on June 18, 2025, with investment led by Access Biotechnology, alongside SV Health Investors and ICG, and including Canaan Partners, SR One, Sanofi Ventures and Schroders Capital. Liam Ratcliffe, Head of Access Biotechnology, said: 'Despite numerous treatments available for neuropsychiatric disorders, a significant unmet need remains with many patients continuing to experience inadequate symptom relief and high rates of relapse. Draig's differentiated approach, which targets core mechanisms underlying these complex conditions, has the potential to deliver a real breakthrough for patients.' Ruth McKernan, co-founder and Executive Chair of Draig, added: 'Making the best molecules to rebalance brain networks has been John and Simon's life work. It has been a professional highlight for me to be part of creating this hugely promising company.' The new funds will enable Draig Therapeutics to advance its lead candidate drug, DT-101, into Phase 2 trials in 2025 for Major Depressive Disorder. The funding will also enable Draig Therapeutics to advance two other drugs towards clinical development in 2026, with best-in-class potential across a range of neuropsychiatric disorders. Rhodri Turner, Research Commercialisation Manager in Cardiff University's Research and Innovation Services, said: 'This investment in Draig Therapeutics is the largest into a Cardiff University spinout company and represents an outstanding success for the university's Medicines Discovery Institute and will significantly accelerate the delivery of much-needed therapeutics to patients.' The Medicines Discovery Institute was launched at Cardiff University in 2017, with supportive funding from the European Regional Development Fund through the Welsh Government's Sêr Cymru scheme, to translate the latest biomedical research into new therapies. Professor Roger Whitaker, Pro Vice-Chancellor for Research, Innovation and Enterprise at Cardiff University, said: 'Draig Therapeutics is an excellent example of how our research ecosystem is driving innovation-led growth and real-world commercialisation. In collaboration with government, the private sector and other stakeholders, we look forward to further building on this success to strengthen the sector's wider role in driving inward investment to Wales. 'Translating our fundamental research into innovative solutions for global challenges is at the heart of what we do. Combined with support for innovation, it is important to remember just how vital Sêr Cymru and other targeted research funding has been in making a step change for Wales. Together we can do much more.' Professor Wendy Larner, Vice-Chancellor and President at Cardiff University, said: 'This achievement exemplifies the huge impact from Cardiff's outstanding research. Our strategy for 2035 reaffirms our global-civic ambitions and the partnership approach that is vital for Wales and the UK. Through our new strategy, Cardiff will continue to strengthen its position for future innovation across the portfolio, for continued economic, social and health benefits.'